Ice bag to face (15-30s) in infants. Valsalva, straining, head-stand in older children. Ocular pressure contraindicated. Carotid massage rarely effective.
Adenosine
Drug of choice (stable)
Rapid IV push: 0.1 mg/kg (max 6 mg). May increase to 0.2 mg/kg (max 12 mg). Requires continuous ECG and immediate direct current (DC) cardioversion availability (risk of inducing atrial fibrillation).
Calcium Channel Blockers
Alternative (older children)
Verapamil reduces cardiac output. Contraindicated in infants <1 year (causes severe hypotension/cardiac arrest).
DC Cardioversion
Hemodynamic instability
Synchronized shock: 0.5–2 J/kg.
Esophageal Pacing
Alternative termination
Pace termination using esophageal catheter.
Chronic & Definitive Management
Medical Therapy:β-blockers represent drugs of choice for chronic suppression. Calcium channel blockers also utilized safely.
Catheter Ablation:
Class IIa indication per PACES/HRS guidelines.
Definitive cure in >95% of patients.
Target: Slow pathway modification.
Risk: Unintended damage to fast pathway causing complete AV block, necessitating permanent pacemaker implantation.
Energy Source: Radiofrequency ablation or cryoablation. Cryoablation preferred near AV node; no permanent AV block reported with this energy source.
Nuances in Congenital Heart Disease (ACHD)
AV node location highly variable in specific congenital lesions.
High-Risk Anatomy: Atrioventricular septal defects (AVSD) and congenitally corrected transposition of the great arteries (L-TGA) feature displaced AV nodal conduction tissue.
Single ventricle anatomy severely complicates mapping and ablation procedures.
Medical management preferred over ablation in complex CHD variants due to high risk of inadvertent AV node injury and heart block.